Get startedLog in
    Picture of Stoke Therapeutics logo

    STOK — Stoke Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapNeutral
    All News

    Brief: Stoke Therapeutics Highlights Strategic Priorities And Anticipated Milestones For 2023

    Picture of Stoke Therapeutics logoStoke Therapeutics
    09/01/2023 13:39
    Jan 9 (Reuters) - Stoke Therapeutics Inc  STOK.O :
    * STOKE THERAPEUTICS HIGHLIGHTS STRATEGIC PRIORITIES AND
ANTICIPATED MILESTONES FOR 2023
    * STOKE - ENDED Q3 WITH $252.2 MILLION IN CASH, CASH
EQUIVALENTS,
MARKETABLE SECURITIES, AND RESTRICTED CASH ANTICIPATED TO FUND
OPERATIONS INTO 2025

Source text for Eikon:  ID:nBw6wYW06a 
Further company coverage:  STOK.O 
 ((reuters.briefs@thomsonreuters.com;))

    Recent news on Stoke Therapeutics

    See all news